Edwards Lifesciences heart valve approved in Europe

Edwards Lifesciences Corp. received European approval to market its Edwards Sapien transcatheter aortic heart valve technology with the RetroFlex transfemoral delivery system. The valve, which is implanted through the leg in a minimally invasive procedure, is for patients with severe aortic heart valve stenosis who are not good candidates for conventional open-heart valve replacement surgery.

View Full Article in:

Orange County Business Journal (Irvine, Calif.) · Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Executive Medical Director
Aspirus Network Inc
Wausau, WI
MEDICAL SCIENCE LIAISON - 14000002RO
Abbott
Columbus, OH
Director, Membership
The Food and Drug Law Institute
Washington, DC
Medical Director - Cataract
Abbott
Santa Ana, CA
Associate Director, Legal
Merck Sharp & Dohme
Whitehouse Station, NJ